Výsledky vyhledávání

Lenalidomide treatment of myelodysplastic syndromes with chromosome 5q deletion: Results from the National Registry of the Italian Drug Agency

Autor: Arcioni, F., Roncadori, A., Di Battista, V., Tura, S., Covezzoli, A., Cundari, S., Mecucci, C., Abbadessa, A., Alterini, R., Santini, V., Cantonetti, M., Buccisano, F., Bacigalupo, A., Sessarego, M., Tonso, A., Ferrero, D., D'Ardia, S., Tarella, C., Cascavilla, N., Bassan, R., Sancetta, R., Cortelezzi, A., Reda, G., Maria D'Arco, A., De Fabritiis, P., Di Renzo, N., Falini, B., Alimena, G., Avanzini, P., Ilariucci, F., Iuliano, F., La Nasa, G., Caocci, G., Defina, M., Latte, G., Palmas, A., Levis, A., Leone, G., Teresa Voso, M., Leoni, P., Poloni, A., Fozza, C., Crugnola, M., Montanaro, M., Spedini, P., Lanza, F., Pizzuti, M., Pane, F., Paolini, R., Borin, L., Rambaldi, A., Rossi, G., Maria Pelizzari, A., Russo, D., D'Emilio, A., Ruggeri, M., Semenzato, G., Specchia, G., Tagariello, G., Sartori, R., Testore, F., Ciravegna, G., Marasca, R., Cimarosto, L., Fontanive, O., Visani, G.

Objective The most typical cytogenetic aberration in myelodysplastic syndromes is del(5q), which, when isolated, is associated with refractory anaemia and good prognosis. Based on high rates of erythroid response and transfusion independence, Lenalid

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f3eff6995b50422779788d1e684e3475
http://hdl.handle.net/11391/1434712

Zobrazit plný text záznamu

Comparative risk/benefit profile of biosimilar and originator erythropoiesis-stimulating agents (ESAs): data from an Italian observational study in nephrology

Autor: Alberto Vaccheri, Anna Covezzoli, Monia Donati, Piera Polidori, Domenico Motola, Giulia Bonaldo, Andrea Roncadori, Stefano Bianchi

Publikováno v: European journal of clinical pharmacology. 74(6)

Purpose: The aim of this multicenter prospective study was to evaluate efficacy and safety of biosimilar erythropoiesis-stimulating agents (ESAs) vs originator, based on data from clinical practice in patients with chronic kidney disease (CKD). Metho

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e3bd5df4a60b7c273f57a0809625dc01
https://pubmed.ncbi.nlm.nih.gov/29429032

Zobrazit plný text záznamu

Comparative safety profiles of intravitreal bevacizumab, ranibizumab and pegaptanib: the analysis of the WHO database of adverse drug reactions

Autor: Nicola Montanaro, Anna Covezzoli, Domenico Motola, Mauro Melis, Elena Buccellato, Monia Donati, Valentino Conti, Chiara Biagi, Mauro Venegoni, Rosario Amato, L Pazzi, Alberto Vaccheri

Publikováno v: European Journal of Clinical Pharmacology. 70:1505-1512

Purpose The purpose of this study is to conduct a comparative analysis of the suspected adverse drug reactions (ADRs) associated with intravitreal bevacizumab, ranibizumab and pegaptanib in the WHO database in order to have a real-life information on

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::07380bde29ce7150e951384f8597d977
https://doi.org/10.1007/s00228-014-1755-1

Zobrazit plný text záznamu

Sodium Thiosulfate for Protection from Cisplatin-Induced Hearing Loss

Publikováno v: The New England journal of medicine, Vol. 378, no.25, p. 2376-2385 (2018)
N Engl J Med
New England Journal of Medicine, Vol. 378, No 25 (2018) pp. 2376-2385

BACKGROUND: Cisplatin chemotherapy and surgery are effective treatments for children with standard-risk hepatoblastoma but may cause considerable and irreversible hearing loss. This trial compared cisplatin with cisplatin plus delayed administration

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::948bb74e3d22b6d4d0b5bb2934618063
https://hdl.handle.net/2078.1/235435

Zobrazit plný text záznamu

Web-based international studies in limited populations of pediatric leukemia

Autor: Daniela Silvestri, Maria Grazia Valsecchi, Anna Covezzoli, Paola De Lorenzo

Publikováno v: Pediatric Blood & Cancer. 50:270-273

Background Recent progress in cancer research leads to the characterization of small subgroups of patients by genetic/biological features. Clinical studies in this setting are frequently promoted by international networks of independent researchers a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::319fed5d38b65eb4215b9491fac7d96e
https://doi.org/10.1002/pbc.21240

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Vyhledávací nástroje:

Upřesnit hledání